Applying quality by design approach for the determination of potent paclitaxel loaded poly(lactic acid) based implants for localized tumor drug delivery-Reference-Cited by-同舟云学术

Applying quality by design approach for the determination of potent paclitaxel loaded poly(lactic acid) based implants for localized tumor drug delivery

Published:2022-04-26 Issue: Volume: Page:1-16
ISSN:0091-4037
Container-title:International Journal of Polymeric Materials and Polymeric Biomaterials
language:en
Short-container-title:International Journal of Polymeric Materials and Polymeric Biomaterials

Author:

Özcan Bülbül Ece¹^ORCID,Üstündağ Okur Neslihan²^ORCID,Mısırlı Duygu³,Cevher Erdal⁴,Tsanaktsis Vasilios⁵,Bingöl Özakpınar Özlem⁶,Siafaka Panoraia I.⁷⁸^ORCID

Affiliation:

1. Department of Pharmaceutical Technology, Faculty of Pharmacy, Istinye University, Istanbul, Turkey

2. Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey

3. Department of Biochemistry, Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey

4. Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey

5. Faculty of Sciences, School of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece

6. Department of Biochemistry, Faculty of Pharmacy, Marmara University, Istanbul, Turkey

7. School of Health Studies, KES College, Nicosia, Cyprus

8. Faculty of Pharmacy, European University Cyprus, Nicosia, Cyprus

Publisher

Informa UK Limited

Subject

Polymers and Plastics,General Chemical Engineering,Analytical Chemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/00914037.2022.2067538

Reference70 articles.

1. World Health Organization. Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer (accessed Jul 20, 2020).

2. Development and characterization of nanobubbles containing paclitaxel and survivin inhibitor YM155 against lung cancer

3. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin

4. Breast cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucoadhesive electrospun nanofibrous poly(ε-caprolactone)/poly(lactic acid) matrices for the ocular delivery of moxifloxacin: a novel application of hyaluronic acid and xanthan gum blend as mucoadhesive coating agent;International Journal of Polymeric Materials and Polymeric Biomaterials;2024-04-15

2. Advancements in wound healing: integrating biomolecules, drug delivery carriers, and targeted therapeutics for enhanced tissue repair;Archives of Microbiology;2024-04

3. A paradigm use of monoclonal antibodies-conjugated nanoparticles in breast cancer treatment: current status and potential approaches;Journal of Drug Targeting;2023-12-28